oho-projects.blogspot.com
OHO: The Digital Agency: Acceleron Pharma Joins the OHO Ranks Looking to Extend Recruitment AdvertisingBoston Web Design, Graphic Design, Web Applications, Zipcar, Jonathan Edwards Center, ICA, Institute of Contemporary Art, Travel and Tourism Web Sites, R
http://oho-projects.blogspot.com/2007/10/acceleron-looks-to-enhance-recruitment.html
OHO: The Digital Agency. Award-Winning Creative Web Applications Life Science Recruitment Advertising. Friday, October 12, 2007. Acceleron Pharma Joins the OHO Ranks Looking to Extend Recruitment Advertising. Has signed with OHO this week becoming our sixth life sciences client along with Synta Pharmaceuticals and Vertex Pharmaceuticals. OHO will be completing a new career fair booth for Acceleron and planning a print advertising strategy. Labels: life science recruitment advertising.
hrbiotechconnect.com
HR BioTech Connect » Members
http://hrbiotechconnect.com/members
HR Biotech Connect Home. April 2017 Event with Radford – Submit Your Questions for our Speakers. Building a Mission-Driven Organization: May 16th. Building and Maintaining a Strong Company Culture. December 2014: Spotlight on the Changing OFCCP Regulations. February 2014: Building High Performance Teams. February 2015: Insights into Personal and Team Communication. HR Roundtable Meeting: April 18th. June 2014 Meeting: Responding to Your CFO: Self-Funding and ACA Readiness. BioTech Journey through the Pha...
openicon.blogspot.com
Dissecting the Bull: July 2015
http://openicon.blogspot.com/2015_07_01_archive.html
Reporting about and analyzing technology stocks. Sunday, July 26, 2015. Buying flurry: Dot Hill, Star Bulk, Ocata Therapeutics, Acceleron, Biogen. It is earnings season so I am very busy, so I am behind in updating followers on my trades. If you want to read the notes I make on the analyst conferences of the stocks I follow, you can find a list of the stocks with links at: Meyers Analyst Conference List. I only sold once stock lately, a bit of my Celgene. I also added shares of Dot Hill. For Seeking Alph...
investor.acceleronpharma.com
Acceleron Pharma » Historic Stock Lookup
http://investor.acceleronpharma.com/stocklookup.cfm
POSTERS, PRESENTATIONS & PUBLICATIONS. Todd James, IRC. Senior Director, Investor Relations and Corporate Communications. Week of October 31, 2016. Oct 31, 2016. Nov 1, 2016. Year End Stock Prices.
avalon-ventures.com
Our Investments - Avalon Ventures
http://www.avalon-ventures.com/our-investments
Middot; Company Website. Middot; Company Website. Middot; Company Website. Middot; Company Website. Middot; Company Website. Middot; Company Website. Middot; Company Website. Middot; Company Website. Middot; Company Website. Middot; Company Website. Avelas Biosciences, Inc. Middot; Company Website. Middot; Company Website. Middot; Company Website. Middot; Company Website. Middot; Company Website. Middot; Company Website. Caliper Life Sciences, Inc. Middot; Company Website. Cambrios Technologies, Corp.
biotechpress.supbiotech.fr
BiotechPress, l'actualité des biotechnologies par les étudiants de Sup'Biotech
http://biotechpress.supbiotech.fr/sante
Ils font avancer la recherche. Les secteurs des biotechs. Formation labellisée par I.A.R. Débouchés après la PAES. Recherche partenariale, LRPIA. Pôle sciences humaines et. Vie associative and culturelle. Se loger, se restaurer. Remise des diplômes. L'avenir est aux nouveaux métiers de la biotechnologie. Vers une alternative au don de sang. Le don de sang ne prend pas de vacances. Ce rappel estival de l'Etablissement Français du sang (EFS). Pour réaliser cette transfusion, l'équipe de Luc Douay a utilisé...
kalynndibble.blogspot.com
Cruising for a Bruising: Hope for a Therapeutic Drug to Treat MD
http://kalynndibble.blogspot.com/2010/08/hope-for-therapeutic-drug-to-treat-md.html
Cruising for a Bruising. Tuesday, August 10, 2010. Hope for a Therapeutic Drug to Treat MD. Dr Kathryn Wagner was one of the speakers who attended the FSH Society International Patient and Researcher Meeting in Las Vegas. (Which there will be more information on to come) She believes that ACE-031, made by Acceleron Pharma Inc., will be effective in FSHD. ACE-031 is a drug being developed to increase muscle mass and strength to treat neuromuscular diseases. From the Accelron website. Thank you for sharing!
SOCIAL ENGAGEMENT